Weight Loss Drugs Could Be Increasing Divorce Rates, Experts Warn

The meteoric rise of GLP-1 receptor agonists like Ozempic and Wegovy, celebrated for their effectiveness in treating obesity, may be hiding an unexpected side effect: an increased risk of divorce among users who experience significant weight loss.

According to historical data from bariatric surgery patients, dramatic weight reduction correlates with higher divorce rates—a pattern that experts believe could be repeating itself as millions turn to these increasingly popular medications.

Per-Arne Svensson, a professor at the Institute of Health and Care Sciences in Sweden who studies the relationship between weight loss and relationship status, cautions that while these drugs offer numerous metabolic benefits, their impact on marriages deserves serious attention.

“The effect likely unfolds in several stages,” Svensson explained. “First, a substantial amount of weight must be lost, which typically occurs within the first year. Subsequently, changes in relationship dynamics may begin to emerge, followed by the legal processes associated with divorce.”

This observation aligns with previous research that found bariatric surgery patients were twice as likely to divorce compared to the general population. The correlation is particularly noteworthy as newer GLP-1 medications approach the effectiveness of surgical interventions.

While GLP-1 drugs are known to help break unhealthy reward-seeking habits like excessive drinking and smoking, Svensson believes the relationship challenges aren’t necessarily due to changes in brain chemistry. Instead, he points to profound psychological and social transformations that accompany significant physical changes.

“Weight loss itself may increase a sense of autonomy or confidence, potentially empowering individuals to leave unhealthy relationships,” he noted. Many patients report substantially altered lifestyles after weight loss, “often involving greater social engagement and increased attention from others.”

These lifestyle shifts can create tension when one partner evolves while the other remains unchanged. A 2013 study supports this theory, finding that when one partner loses significant weight while the other maintains their size, feelings of insecurity and criticism often emerge from the unchanged partner.

The psychological dynamics at play are complex. Some individuals may have entered or remained in relationships partly due to lower self-esteem connected to their weight. As their confidence grows with weight loss, they might reevaluate relationship choices made during a different phase of life.

“Currently, surgery leads to greater average weight loss, and its impact on relationships is therefore likely to be more pronounced,” Svensson said. “However, as newer, more effective medications are developed, we may soon see comparable levels of weight loss to those achieved with surgery.”

Not all weight loss stories end in separation. Svensson notes that for singles, weight loss can actually increase opportunities for new relationships. “Among individuals who are single, the likelihood of forming a new relationship also increases substantially after weight loss,” he said. “While it may be somewhat discouraging to acknowledge the role of appearance in partner selection, finding a new romantic partner is nevertheless one of the most significant events in a person’s life.”

For couples concerned about these potential relationship challenges, experts recommend a collaborative approach to health and weight management. If one partner pursues wellness goals, involving the spouse in healthy lifestyle changes can create a shared journey rather than one that pulls the couple apart.

“There may be clear advantages to partners undertaking weight-loss treatment together,” Svensson suggests, provided that both have a clinical need for the intervention.

As GLP-1 medications continue to transform the landscape of obesity treatment—with an estimated 7% of American adults having tried these drugs according to recent surveys—understanding their potential impact beyond physical health becomes increasingly important for healthcare providers, patients, and their families.

The pharmaceutical companies manufacturing these medications have not yet issued formal responses regarding these relationship findings, leaving patients to weigh another potential consideration when beginning treatment with these increasingly popular drugs.